Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.5.0.2
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Sep. 30, 2016
Sep. 30, 2015
Revenues        
Product $ 3,809 $ 3,404 $ 7,318 $ 6,320
Product licensing fees and royalties 75 339 150 786
Service 224 311 451 628
Total revenues 4,108 4,054 7,919 7,734
Cost of revenues        
Product 1,822 1,717 3,529 3,233
Service 204 247 389 538
Total cost of revenues 2,026 1,964 3,918 3,771
Gross profit 2,082 2,090 4,001 3,963
Operating expenses        
Research and development 379 412 739 879
Selling, general and administrative 3,643 3,536 7,773 7,253
Total operating expenses 4,022 3,948 8,512 8,132
Loss from operations (1,940) (1,858) (4,511) (4,169)
Interest expense (1) (1) (2) (1)
Interest income 1 1 2 1
Gain due to change in fair value of derivative instruments 0 65 0 6
Other (expense) income, net (9) 30 (6) 60
Net loss $ (1,949) $ (1,763) $ (4,517) $ (4,103)
Net loss per common share: basic and diluted $ (.46) $ (.54) $ (1.08) $ (1.30)
Weighted-average number of common shares used in common per share calculations: basic and diluted 4,202 3,251 4,195 3,144
Other comprehensive loss        
Net loss $ (1,949) $ (1,763) $ (4,517) $ (4,103)
Foreign currency translation adjustments (168) (253) (401) (324)
Comprehensive loss $ (2,117) $ (2,016) $ (4,918) $ (4,427)